A new study obtained exclusively by Fox News Digital reveals that the opioid crisis cost the U.S. $2.7 trillion in 2023. The Council of Economic Advisers report highlights the significant economic burden associated with opioid-related deaths, loss of productivity, healthcare costs, and crime.
FIRST ON FOX: The opioid crisis under the Biden administration cost the U.S. $2.7 trillion in 2023 alone, a new study exclusively obtained by Fox News Digital shows. The Council of Economic Advisers, an agency within the executive office that advises the president on economic policy, released a study on Friday, detailing that the opioid epidemic cost the U.S. $2.
Canada has played a central role in these challenges, including by failing to devote sufficient attention and resources or meaningfully coordinate with United States law enforcement partners to effectively stem the tide of illicit drugs.
Economics Politics OPIOID CRISIS ECONOMICS TARIFFS FENTANYL HEALTHCARE COSTS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Opioid Crisis Cost US $2.7 Trillion in 2023, Study FindsA new study obtained by Fox News Digital reveals the devastating economic impact of the opioid crisis under the Biden administration, costing the U.S. $2.7 trillion in 2023 alone. The Council of Economic Advisers study highlights the widespread costs associated with opioid addiction, including loss of life, reduced quality of life, decreased labor productivity, crime, and healthcare expenses.
Read more »
Trump should fight the opioid crisis with non-opioid alternativesPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Pound Plunges to Lowest Level Since Late 2023 Amid Economic CrisisThe British pound is experiencing its lowest value since late 2023 due to a combination of economic challenges and investor concerns about the UK's financial stability.
Read more »
New Non-Opioid Pain Drug Shows Promise but Faces Cost HurdlesJournavx, a new drug designed to alleviate pain without the addictive risks associated with opioids, has shown promising results in clinical trials. While it provides more relief than a placebo, it's not yet superior to common opioids. The drug's unique mechanism of action, targeting pain signals before they reach the brain, sets it apart. However, Journavx's high cost, at $15.50 per pill compared to generic opioids costing less than $1, raises concerns about accessibility.
Read more »
Kentucky Settles with Kroger for $270 Million Over Role in Opioid CrisisKentucky Attorney General secures $270 million settlement with Kroger for its alleged role in fueling the opioid epidemic. The funds will support prevention and recovery efforts in the state.
Read more »
Kentucky Gets $110 Million to Combat Opioid Crisis From Kroger SettlementKentucky will receive $110 million from a settlement with Kroger over its alleged role in fueling the opioid epidemic. Attorney General Russell Coleman said the money will be used for prevention and recovery efforts.
Read more »